Xiuhua Wu
Biographic Data
| ID | 7961395 |
|---|---|
| NAME | Xiuhua Wu |
| GIVEN NAMES | Xiuhua |
| FAMILY NAME | Wu |
| SIGNATURE | WU X |
| AFFILIATIONS | Sun Yat-sen University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Unraveling personality in mood disorders
Neuroticism is a key marker of psychiatric illness, while agreeableness distinguishes BD from MDD. The associations between personality, illness severity, and treatment engagement highlight their potential clinical relevance and need for further study
Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder
In BDD, immune-inhibition is persistently predominant, while in mild-to-moderate BDM, immune system is activated but inhibited in severe BDM. The dynamic change of serum inflammatory markers suggests that alteration of peripheral inflammatory markers in BD is state-dependent instead of trait-marked
Case Report
Background: Medication non-adherence is prevalent in patients with bipolar disorder (BD). Long-acting injectable antipsychotics (LAIAs) are widely used to improve compliance with treatment. This study aimed to illustrate the effectiveness, compliance, and safety profile of once-monthly paliperidone palmitate (PP1M), a novel therapeutic LAIA, in the management of bipolar I disorder (BDI). Method: A prospective follow-up was arranged to 11 BDI pati…
No prominent works on this page.
Case Report
Background: Medication non-adherence is prevalent in patients with bipolar disorder (BD). Long-acting injectable antipsychotics (LAIAs) are widely used to improve compliance with treatment. This study aimed to illustrate the effectiveness, compliance, and safety profile of once-monthly paliperidone palmitate (PP1M), a novel therapeutic LAIA, in the management of bipolar I disorder (BDI). Method: A prospective follow-up was arranged to 11 BDI pati…
Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder
In BDD, immune-inhibition is persistently predominant, while in mild-to-moderate BDM, immune system is activated but inhibited in severe BDM. The dynamic change of serum inflammatory markers suggests that alteration of peripheral inflammatory markers in BD is state-dependent instead of trait-marked
Unraveling personality in mood disorders
Neuroticism is a key marker of psychiatric illness, while agreeableness distinguishes BD from MDD. The associations between personality, illness severity, and treatment engagement highlight their potential clinical relevance and need for further study
Bipolar disorder (3 works) · Bipolar Disorder and Treatment (3 works) · Internal Medicine (2 works) · Lithium (medication (2 works) · Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Adiponectin (1 work) · Adjunctive treatment (1 work) · Agreeableness (1 work)